Open Access Open Access  Restricted Access Subscription Access

Understanding Drugs for Inflammatory Hepatic Diseases: Managing Liver Health

Ambica Prasad M., Ramanjaneyuly D. V., Sony Sharlet E., Sravani Pragna K., Muralinath E., Mohan Naidu K., Srinivas Prasad, Jayinder Paul Singh. G, Panjan Ghosh. P., Kalyan C., Archana Jain, Guruprasad M.

Abstract


Inflammatory hepatic diseases encompass a range of conditions influencing  the liver, from hepatitis to liver cirrhosis. Managing these conditions often involves a multifaceted approach, with medications playing a critical  role in alleviating symptoms and slowing disease progression. Understanding the various drugs used in treating inflammatory hepatic diseases is essential for healthcare providers and patients alike.


Full Text:

PDF

References


Taylor CP, Traynelis SF, Siffert J, Pope LE, Matsumoto RR. Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use. Pharmacol Ther. 2016 Aug;164:170-82. [PubMed]

Pioro EP. Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect. Neurol Ther. 2014 Jun;3(1):15-28. [PMC free article] [PubMed]

Patatanian E, Casselman J. Dextromethorphan/quinidine for the treatment of pseudobulbar affect. Consult Pharm. 2014 Apr;29(4):264-9. [PubMed]

Nguyen L, Thomas KL, Lucke-Wold BP, Cavendish JZ, Crowe MS, Matsumoto RR. Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacol Ther. 2016 Mar;159:1-22. [PubMed]

Corado CR, McKemie DS, Knych HK. Pharmacokinetics of dextromethorphan and its metabolites in horses following a single oral administration. Drug Test Anal. 2017 Jun;9(6):880-887. [PubMed]

Werling LL, Lauterbach EC, Calef U. Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action. Neurologist. 2007 Sep;13(5):272-93. [PubMed]

Wadelius M, Darj E, Frenne G, Rane A. Induction of CYP2D6 in pregnancy. Clin Pharmacol Ther. 1997 Oct;62(4):400-7. [PubMed]

Tracy TS, Venkataramanan R, Glover DD, Caritis SN., National Institute for Child Health and Human Development Network of Maternal-Fetal-Medicine Units. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. Am J Obstet Gynecol. 2005 Feb;192(2):633-9. [PubMed]

Drugs and Lactation Database (LactMed®) [Internet]. National Institute of Child Health and Human Development; Bethesda (MD): Dec 15, 2023. Dextromethorphan. [PubMed]

Lauterbach EC. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan. Med Hypotheses. 2012 Jun;78(6):693-702. [PubMed]

Bem JL, Peck R. Dextromethorphan. An overview of safety issues. Drug Saf. 1992 May-Jun;7(3):190-9. [PubMed]

Ganetsky M, Babu KM, Boyer EW. Serotonin syndrome in dextromethorphan ingestion responsive to propofol therapy. Pediatr Emerg Care. 2007 Nov;23(11):829-31. [PubMed]


Refbacks

  • There are currently no refbacks.